January 15, 2026 | Generative AI, Intelligent Commercialization
Learn how a next-generation approach to field training – powered by GenAI and avatar simulations and enabled through Intelligent Commercialization™ – can transform field force effectiveness by delivering scalable, always-on, confidence-building practice for Medical Affairs and Commercial teams.

In this webcast, Inizio examine why traditional, analog models of training are no longer enough in an environment where HCPs have less time, higher expectations, and demand both scientific depth and concise value. You’ll gain an understanding of the evolving “menu” of AI-enabled upskilling options, what truly differentiates those that drive measurable impact, and a practical framework to evaluate and integrate these capabilities into your own field development strategy.
Watch now to learn how Inizio delivers AI-enabled field training through Intelligent Commercialization™ and how this approach can elevate the effectiveness of your Medical and Commercial teams.
This content was provided by Inizio
Latest Content from Inizio
As predicted, the vaccine market in emerging and developing countries has continued to expand. While the global vaccine market is expected to grow at around 12% annually over the next…
Tuesday 19th July 15:00 BST/10:00 EDT/16:00 CEST
The patient journey is changing. Patients are now much more educated and engaged. They have access to information and want to be involved in decisions around their treatment programme. Technology…
The challenge:Our client needed to understand moleculardiagnostic testing growth opportunities for a new biomarker in oncology. They wanted to understand the current market landscape, identify potential leverage points that would maximise use of the biomarker…
Research Partnership has published new Living with rheumatoid arthritis (RA) EU and US market reports for 2016.
Published in PBIRG Perspective, May 2016, vol. 18 No.1, By Julie Denny, Marketing Director
Immuno-oncology therapies which harness the body’s own defences to fight off tumours are widely acknowledged as the new frontier in cancer treatment. However, these therapies come with a very high price…
Published in Quirk’s Marketing Research Review, April 2016, By Marc Yates, Director of Emerging Markets
Pegasus wins the prestigious “EMEA Healthcare PR Consultancy of the Year” award at the recent Sabre Awards in Berlin, organised by The Holmes Report.
Tom has been appointed a Director in our Philadelphia office. He has over 25 years’ experience in healthcare research and has an extensive background in both quantitative and qualitative research,…
